Cybin Inc. - Price History
Monthly price history for CYBN (Cybin Inc.)
| Date | Adjusted price | Real price |
|---|---|---|
| May 2024 | $0.35 | $0.35 |
| April 2024 | $0.35 | $0.35 |
| March 2024 | $0.41 | $0.41 |
| February 2024 | $0.35 | $0.35 |
| January 2024 | $0.38 | $0.38 |
| December 2023 | $0.41 | $0.41 |
| November 2023 | $0.45 | $0.45 |
| October 2023 | $0.65 | $0.65 |
| September 2023 | $0.53 | $0.53 |
| August 2023 | $0.31 | $0.31 |
| July 2023 | $0.40 | $0.40 |
| June 2023 | $0.38 | $0.38 |
| May 2023 | $0.27 | $0.27 |
| April 2023 | $0.35 | $0.35 |
| March 2023 | $0.38 | $0.38 |
| February 2023 | $0.52 | $0.52 |
| January 2023 | $0.39 | $0.39 |
| December 2022 | $0.30 | $0.30 |
| November 2022 | $0.37 | $0.37 |
| October 2022 | $0.45 | $0.45 |
| September 2022 | $0.48 | $0.48 |
| August 2022 | $1.11 | $1.11 |
| July 2022 | $0.59 | $0.59 |
| June 2022 | $0.56 | $0.56 |
| May 2022 | $0.68 | $0.68 |
| April 2022 | $0.58 | $0.58 |
| March 2022 | $0.82 | $0.82 |
| February 2022 | $0.90 | $0.90 |
| January 2022 | $1.05 | $1.05 |
| December 2021 | $1.20 | $1.20 |
| November 2021 | $1.47 | $1.47 |
| October 2021 | $1.87 | $1.87 |
| September 2021 | $2.19 | $2.19 |
| August 2021 | $2.80 | $2.80 |
| July 2021 | $3.05 | $3.05 |
| June 2021 | $2.04 | $2.04 |
| May 2021 | $1.42 | $1.42 |
| April 2021 | $1.80 | $1.80 |
| March 2021 | $1.04 | $1.04 |
| February 2021 | $1.27 | $1.27 |
| January 2021 | $1.65 | $1.65 |
| December 2020 | $1.49 | $1.49 |
| November 2020 | $0.68 | $0.68 |
| October 2020 | $0.52 | $0.08 |
| September 2020 | $0.52 | $0.08 |
| August 2020 | $0.52 | $0.08 |
| July 2020 | $0.52 | $0.08 |
| June 2020 | $0.52 | $0.08 |
| May 2020 | $0.52 | $0.08 |
| April 2020 | $0.36 | $0.05 |
| March 2020 | $0.34 | $0.05 |
| February 2020 | $1.32 | $0.20 |
| January 2020 | $1.32 | $0.20 |
| December 2019 | $1.32 | $0.20 |
| November 2019 | $1.32 | $0.20 |
| October 2019 | $1.32 | $0.20 |
| September 2019 | $1.32 | $0.20 |
CYBN
Price: $0.35
52 week price:
Earnings Per Share: -0.22 USD
P/E Ratio: -1.83
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Volume: 1.6 million
Market Capitalization: 288.6 million